Activation of p53 by protein inhibitor of activated Stat1 (PIAS1)

被引:73
作者
Megidish, T
Xu, JH
Xu, CW
机构
[1] Sloan Kettering Inst, Mol Pharmacol Program, New York, NY 10021 USA
[2] Cornell Univ, Grad Sch Med Sci, Sloan Kettering Div, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.C200001200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor protein p53 functions as a transcriptional factor that activates genes controlling cell cycle arrest and apoptosis. Here, we report that protein inhibitor of activated Stat1 (PIAS1) interacts with the tetramerization and C-terminal regulatory domains of p53 in yeast two-hybrid analyses. Endogenous PIAS1 is also associated with endogenous p53 in mammalian cells. Ectopic expression of PIAS1 activates p53-mediated expression in mouse embryonic fibroblast cells (p53(-/-)) as well as a variety of other cell lines. Furthermore, ectopic expression of PIAS1 induces p53-mediated expression of cyclin-dependent kinase inhibitor p21 and G, arrest of the cell cycle in H1299 cells. In addition, a PIAS1 mutant without the RING-finger domain required for sumoylation could still activate p53-mediated gene expression, indicating that activation of p53 by PIAS1 does not require the RING-finger domain. Taken together, our results suggest that PIAS1 is a novel activator of p53.
引用
收藏
页码:8255 / 8259
页数:5
相关论文
共 37 条
  • [1] The C-terminus of p53: the more you learn the less you know
    Ahn, J
    Prives, C
    [J]. NATURE STRUCTURAL BIOLOGY, 2001, 8 (09) : 730 - 732
  • [2] Post-translational modifications and activation of p53 by genotoxic stresses
    Appella, E
    Anderson, CW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10): : 2764 - 2772
  • [3] A Drosophila PIAS homologue negatively regulates stat92E
    Betz, A
    Lampen, N
    Martinek, S
    Young, MW
    Darnell, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) : 9563 - 9568
  • [4] Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress
    Buschmann, T
    Potapova, O
    Bar-Shira, A
    Ivanov, VN
    Fuchs, SY
    Henderson, S
    Fried, VA
    Minamoto, T
    Alarcon-Vargas, D
    Pincus, MR
    Gaarde, WA
    Holbrook, NJ
    Shiloh, Y
    Ronai, Z
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (08) : 2743 - 2754
  • [5] The role of tetramerization in p53 function
    Chène, P
    [J]. ONCOGENE, 2001, 20 (21) : 2611 - 2617
  • [6] INTERACTION MATING REVEALS BINARY AND TERNARY CONNECTIONS BETWEEN DROSOPHILA CELL-CYCLE REGULATORS
    FINLEY, RL
    BRENT, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) : 12980 - 12984
  • [7] MBP1: a novel mutant p53-specific protein partner with oncogenic properties
    Gallagher, WM
    Argentini, M
    Sierra, V
    Bracco, L
    Debussche, L
    Conseiller, E
    [J]. ONCOGENE, 1999, 18 (24) : 3608 - 3616
  • [8] Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
    Gostissa, M
    Hengstermann, A
    Fogal, V
    Sandy, P
    Schwarz, SE
    Scheffner, M
    Del Sal, G
    [J]. EMBO JOURNAL, 1999, 18 (22) : 6462 - 6471
  • [9] Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells
    Gross, M
    Liu, B
    Tan, JA
    French, FS
    Carey, M
    Shuai, K
    [J]. ONCOGENE, 2001, 20 (29) : 3880 - 3887
  • [10] CDI1, A HUMAN G1-PHASE AND S-PHASE PROTEIN PHOSPHATASE THAT ASSOCIATES WITH CDK2
    GYURIS, J
    GOLEMIS, E
    CHERTKOV, H
    BRENT, R
    [J]. CELL, 1993, 75 (04) : 791 - 803